Effect of Dairy on Cognitive Performance in Children

Sponsor
Ryerson University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05767983
Collaborator
Dairy Management Inc. (Industry), National Dairy Council (Other)
60
1
5
21.5
2.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effects of dairy consumption on short-term cognitive performance, subjective mood and emotions, and glycemic response in healthy children aged 9 - 14 years. The investigators hypothesize that the consumption of dairy products as a mid-morning snack will improve mood and cognitive performance in children. Furthermore, the investigators hypothesize that all dairy products consumed as a mid-morning snack will imbue more benefits on mood and cognitive performance over 2-hours compared to fruit juice or snack skipping.

Condition or Disease Intervention/Treatment Phase
  • Other: Fat-free milk
  • Other: Fat-free yogurt
  • Other: Low-fat cheese
  • Other: Fruit juice
  • Other: Snack skipping
N/A

Detailed Description

A randomized within-subject repeated measures experiment will be used to study the effects of dairy product consumption on cognitive performance, subjective mood and emotions, and blood glucose in healthy 9 - 14 year old children. Participants will consume, in a random order on separate mornings, one of the five treatments: (a) milk, (b) yogurt, (c) cheese, (d) fruit juice, or (e) snack skipping. Subjective mood/emotions and cognitive domains (learning and memory, spatial working memory, attention, processing speed, and executive function) will be assessed at baseline (0-min), and 15-, 30-, 60-, and 120-min following treatment consumption. Blood glucose measurements will be collected using the Freestyle Libre 2 continuous glucose monitoring system.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of Dairy on Cognitive Performance, Subjective Appetite and Glycemic Response in Children
Actual Study Start Date :
Oct 18, 2022
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fat-free milk

Treatment

Other: Fat-free milk
Fat-free milk (500 mL, skim, 0%, Lactantia PurFiltre) will provide 180 kcal, 0 g fat, 26 g carbohydrate, and 18 g protein. Treatments matched for calories (180 kcal).

Experimental: Fat-free yogurt

Treatment

Other: Fat-free yogurt
Fat-free yogurt (242 g, vanilla, 0% Greek, Oikos) will provide 180 kcal, 0 g fat, 23.5 g carbohydrate, and 19.4 g protein. Treatments matched for calories (180 kcal).

Experimental: Low-fat cheese

Treatment

Other: Low-fat cheese
Low-fat cheese (60 g, mild marble cheddar, 40% less fat, Selection) will provide 180 kcal, 10 g fat, 2 g carbohydrate, and 16 g protein. Treatments matched for calories (180 kcal).

Experimental: Fruit juice

Treatment

Other: Fruit juice
Fruit juice (450 mL, Fruité® Fruit Punch) will provide 180 kcal, 0 g fat, 46.8 g carbohydrate, and 0 g protein. Treatments matched for calories (180 kcal).

Experimental: Snack skipping

Treatment

Other: Snack skipping
Water control treatment (no caloric contribution). Matched for volume (500 mL) to fat-free milk treatment.

Outcome Measures

Primary Outcome Measures

  1. Learning and short-term memory [Change from baseline (measured at 0-minutes before treatment) and at 15-minutes, 30-minutes, 60-minutes and 120-minutes post-treatment consumption]

    Cognitive performance tests will be administered via a Dell tablet (Millisecond, Inquisit Web) and paper/pen. Learning and short-term memory will be assessed using an immediate and delayed Word Recall Test (accuracy).

  2. Spatial working memory [Change from baseline (measured at 0-minutes before treatment) and at 15-minutes, 30-minutes, 60-minutes and 120-minutes post-treatment consumption]

    Cognitive performance tests will be administered via a Dell tablet (Millisecond, Inquisit Web) and paper/pen. Spatial working memory will be assessed using the forward and backward versions of the Corsi Block Test (accuracy).

  3. Sustained attention [Change from baseline (measured at 0-minutes before treatment) and at 15-minutes, 30-minutes, 60-minutes and 120-minutes post-treatment consumption]

    Cognitive performance tests will be administered via a Dell tablet (Millisecond, Inquisit Web) and paper/pen. Sustained attention and processing speed will be assessed using the Continuous Performance Test (CPT) (accuracy and reaction time).

  4. Executive function [Change from baseline (measured at 0-minutes before treatment) and at 15-minutes, 30-minutes, 60-minutes and 120-minutes post-treatment consumption]

    Cognitive performance tests will be administered via a Dell tablet (Millisecond, Inquisit Web) and paper/pen. Executive function and selective attention will be assessed using the Flanker Task (accuracy and reaction time).

Secondary Outcome Measures

  1. Glycemic response [Change from baseline (measured at 0-minutes before treatment) and 15-minutes, 30-minutes, 45-minutes, 60-minutes, 75-minutes, 90-minutes, 105-minutes and 120-minutes post-treatment consumption]

    Blood glucose (mmol/L). Blood glucose concentrations will be measured using a Freestyle Libre 2 continuous glucose monitoring (CGM) and flash-glucose system.

  2. Subjective mood and emotion [Change from baseline (measured at 0-minutes before treatment) and at 15-minutes, 30-minutes, 60-minutes and 120-minutes post-treatment consumption]

    A visual analogue scale (VAS) with thirteen questions will be administered to assess subjective emotions and mood (aggression, anger, excitement, disappointment, happiness, upset, frustration, alertness, sadness, tension, exhaustion, calmness, sleepiness, and wellness). Individual questions will be used to form a composite emotion score. Each VAS will be administered via a digital software application (Express VAS, Toronto, Ontario, Canada) on a Dell tablet where children will place an 'X" on the VAS line (100 unit scale) to describe their feelings.

Eligibility Criteria

Criteria

Ages Eligible for Study:
9 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 9 to 14 years of age;

  • Normal weight defined as between the 15th and 80th percentile for age and biological sex at birth according to the World Health Organization growth (WHO) charts.

Exclusion Criteria:
  • Children with overweight/ obesity;

  • Children with food sensitivities or allergies to dairy, gluten or any foods used in the study;

  • Children with any diagnosed learning, emotional, or behavioural disabilities;

  • Children taking any medications that may influence cognitive performance.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre for Urban Innovation (CUI-109), Toronto Metropolitan University (Formerly Ryerson University) Toronto Ontario Canada M5B 2K3

Sponsors and Collaborators

  • Ryerson University
  • Dairy Management Inc.
  • National Dairy Council

Investigators

  • Principal Investigator: Nick Bellissimo, PhD, Ryerson University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nick Bellissimo, Associate Professor, Ryerson University
ClinicalTrials.gov Identifier:
NCT05767983
Other Study ID Numbers:
  • Temp ID
First Posted:
Mar 14, 2023
Last Update Posted:
Mar 14, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nick Bellissimo, Associate Professor, Ryerson University

Study Results

No Results Posted as of Mar 14, 2023